NEXGEL
Logotype for NEXGEL Inc

NEXGEL (NXGL) investor relations material

NEXGEL Q3 2026 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for NEXGEL Inc
Q3 2026 earnings summary16 Nov, 2026

Executive summary

  • Q3 2026 revenue rose 8.4% YoY to $3.179 million, but gross margin fell to 35.4% and operating loss widened to $2.539 million.

  • Nine-month revenue increased 10.3% to $9.515 million, while net loss attributable to shareholders widened to $5.676 million; management cited substantial doubt about going concern.

Financial highlights

  • Q3 revenue was $3.179 million vs. $2.934 million; gross profit was $1.125 million vs. $1.243 million.

  • Q3 operating expenses rose to $3.664 million from $1.968 million, primarily reflecting BioNx launch costs and Celularity license amortization.

  • Q3 net loss was $1.093 million; loss attributable to shareholders was $1.112 million, or $2.28 per diluted share.

  • 9M revenue was $9.515 million vs. $8.625 million; gross profit declined to $3.294 million from $3.690 million.

  • 9M net loss attributable to shareholders was $5.676 million vs. $2.030 million; diluted loss per share was $12.61 vs. $5.23.

Outlook and guidance

  • Near-term losses are expected to continue; long-term viability depends on growing products and reaching profitable operations.

  • BioNx is expected to contribute positive operating cash flow and improve liquidity, but there is no assurance it will do so.

  • Additional capital is expected to be needed even if the proposed Fountainhead merger and note conversions proceed.

  • Remaining cash consideration payable to Celularity was $1.798 million; other near-term cash needs include reimbursements, note interest and legal costs.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
Research faster. Power your platform.

Next NEXGEL earnings date

Logotype for NEXGEL Inc
Q4 202629 Mar, 2027
NEXGEL
Cover every name on your watchlist this earnings season.
Automations, AI chat, and live calls across 16,000+ companies.
Book demo

Next NEXGEL earnings date

Logotype for NEXGEL Inc
Q4 202629 Mar, 2027

AI chat

Ask anything. Verify everything.

Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn more

Find what matters

AI across all first-party IR material. Live calls, transcripts, slides, filings.
A cited source card from Adobe's CFO alongside a list of forward-looking statements

Trust every finding

50m+ first-party documents. Every output traceable to its source.

Automations

Zero in on what matters

Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more
An automation set to trigger on the first published earnings document for GE Aerospace

Event-triggered research

Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.
An automation scheduled to run weekly on Mondays at 09:00

Scheduled research

Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.

Live audio & transcripts

Be first

Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more
A live LVMH Q2 2026 earnings call playing in Quartr

Live earnings calls

Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.
A live transcript excerpt from LVMH's Chairman and CEO Bernard Arnault

Live transcripts

Speaker-by-speaker, in real time. Searchable across every live and historical call.

Quartr MCP connects your AI environment to 17K+ public companies

Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more

Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.

Jamie Ross

Investment Manager, GAM Investments

GAM
GAM

Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.

Tom O'Hara

Investment Director

Ciena
Ciena

Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.

Gregg Lampf

VP of Investor Relations

Frequently asked questions

NEXGEL, Inc. is a company that specializes in the development and manufacturing of ultra-gentle, high-water-content hydrogels. These hydrogels are used in various healthcare and consumer applications, particularly in medical, beauty, and over-the-counter (OTC) products. The company's products include branded items such as Silverseal, Hexagels, Turfguard, Kenkoderm, and Dermablock. In addition to their proprietary brands, NEXGEL also engages in strategic contract manufacturing partnerships with leading consumer healthcare companies, offering customized hydrogel solutions that incorporate natural ingredients designed to be worn comfortably on the skin. NEXGEL is headquartered in Langhorne, Pennsylvania, and its shares are listed on the NASDAQ.